Does IPILIMUMAB Cause Dermatitis bullous? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Dermatitis bullous have been filed in association with IPILIMUMAB (YERVOY). This represents 0.1% of all adverse event reports for IPILIMUMAB.
20
Reports of Dermatitis bullous with IPILIMUMAB
0.1%
of all IPILIMUMAB reports
6
Deaths
9
Hospitalizations
How Dangerous Is Dermatitis bullous From IPILIMUMAB?
Of the 20 reports, 6 (30.0%) resulted in death, 9 (45.0%) required hospitalization, and 1 (5.0%) were considered life-threatening.
Is Dermatitis bullous Listed in the Official Label?
Yes, Dermatitis bullous is listed as a known adverse reaction in the official FDA drug label for IPILIMUMAB.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Dermatitis bullous?
LINAGLIPTIN (275)
ACETAMINOPHEN (157)
IBUPROFEN (142)
FUROSEMIDE (140)
PEMBROLIZUMAB (136)
METHOTREXATE (129)
VANCOMYCIN (115)
CARBOPLATIN (105)
ESOMEPRAZOLE (103)
NIVOLUMAB (103)
Which IPILIMUMAB Alternatives Have Lower Dermatitis bullous Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN